ERβ, in particular, plays a significant role in breast cancer, often acting as a tumor suppressor; while ERα promotes cancer cell proliferation, ERβ tends to inhibit it, and high levels of this protein are associated with better prognosis and improved survival rates [90]. This evidence concerns the gene ESR2 and neoplasm.